358 related articles for article (PubMed ID: 2245691)
1. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.
Danner RL; Natanson C; Elin RJ; Hosseini JM; Banks S; MacVittie TJ; Parrillo JE
Chest; 1990 Dec; 98(6):1480-7. PubMed ID: 2245691
[TBL] [Abstract][Full Text] [Related]
2. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.
Natanson C; Danner RL; Elin RJ; Hosseini JM; Peart KW; Banks SM; MacVittie TJ; Walker RI; Parrillo JE
J Clin Invest; 1989 Jan; 83(1):243-51. PubMed ID: 2642920
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.
Natanson C; Eichenholz PW; Danner RL; Eichacker PQ; Hoffman WD; Kuo GC; Banks SM; MacVittie TJ; Parrillo JE
J Exp Med; 1989 Mar; 169(3):823-32. PubMed ID: 2647895
[TBL] [Abstract][Full Text] [Related]
4. Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.
Hoffman WD; Danner RL; Quezado ZM; Banks SM; Elin RJ; Hosseini JM; Natanson C
Infect Immun; 1996 Feb; 64(2):406-12. PubMed ID: 8550184
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular performance with E. coli challenges in a canine model of human sepsis.
Natanson C; Danner RL; Fink MP; MacVittie TJ; Walker RI; Conklin JJ; Parrillo JE
Am J Physiol; 1988 Mar; 254(3 Pt 2):H558-69. PubMed ID: 3279822
[TBL] [Abstract][Full Text] [Related]
6. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.
Natanson C; Fink MP; Ballantyne HK; MacVittie TJ; Conklin JJ; Parrillo JE
J Clin Invest; 1986 Jul; 78(1):259-70. PubMed ID: 3722379
[TBL] [Abstract][Full Text] [Related]
7. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.
Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD
J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis.
Eichacker PQ; Waisman Y; Natanson C; Farese A; Hoffman WD; Banks SM; MacVittie TJ
J Appl Physiol (1985); 1994 Nov; 77(5):2366-73. PubMed ID: 7532649
[TBL] [Abstract][Full Text] [Related]
9. The cardiocirculatory and metabolic effects of endotoxin challenge after canine resuscitated hemorrhagic shock.
Horton J
J Trauma; 1989 Feb; 29(2):195-202. PubMed ID: 2563778
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock.
Wilson MF; Brackett DJ; Tompkins P; Benjamin B; Archer LT; Hinshaw LB
Adv Shock Res; 1981; 6():15-26. PubMed ID: 6760706
[TBL] [Abstract][Full Text] [Related]
11. Contribution of peripheral blood pooling to central hemodynamic disturbances during endotoxin insult in intact dogs.
D'Orio V; Wahlen C; Naldi M; Fossion A; Juchmes J; Marcelle R
Crit Care Med; 1989 Dec; 17(12):1314-9. PubMed ID: 2686936
[TBL] [Abstract][Full Text] [Related]
12. The cardiovascular response of normal humans to the administration of endotoxin.
Suffredini AF; Fromm RE; Parker MM; Brenner M; Kovacs JA; Wesley RA; Parrillo JE
N Engl J Med; 1989 Aug; 321(5):280-7. PubMed ID: 2664516
[TBL] [Abstract][Full Text] [Related]
13. Cardiorespiratory effects of Pseudomonas and E. coli endotoxins in the awake dog.
Miller TH; Priano LL; Jorgensen JH; Traber DL
Am J Physiol; 1977 Jun; 232(6):H682-9. PubMed ID: 406796
[TBL] [Abstract][Full Text] [Related]
14. Serial measures of total body oxygen consumption in an awake canine model of septic shock.
Eichacker PQ; Hoffman WD; Danner RL; Banks SM; Richmond S; Fitz Y; Natanson C
Am J Respir Crit Care Med; 1996 Jul; 154(1):68-75. PubMed ID: 8680702
[TBL] [Abstract][Full Text] [Related]
15. Plasma endotoxin concentration in healthy primates and during E. coli-induced shock.
Wessels BC; Wells MT; Gaffin SL; Brock-Utne JG; Gathiram P; Hinshaw LB
Crit Care Med; 1988 Jun; 16(6):601-5. PubMed ID: 3286118
[TBL] [Abstract][Full Text] [Related]
16. A new canine model of endotoxin shock.
Evans SF; Hinds CJ; Varley JG
Br J Pharmacol; 1984 Oct; 83(2):433-42. PubMed ID: 6435710
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
Manson NH; Hess ML
Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034
[TBL] [Abstract][Full Text] [Related]
18. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.
Quezado ZM; Hoffman WD; Winkelstein JA; Yatsiv I; Koev CA; Cork LC; Elin RJ; Eichacker PQ; Natanson C
J Exp Med; 1994 Feb; 179(2):569-78. PubMed ID: 8294868
[TBL] [Abstract][Full Text] [Related]
19. Augmented venous return: a model of left ventricular afterload reduction during the course of endotoxin shock.
Hess ML; Krause SM; Komwatana P; Eaton R; Okabe E
Circ Shock; 1981; 8(4):435-50. PubMed ID: 7023737
[TBL] [Abstract][Full Text] [Related]
20. Endotoxemia in human septic shock.
Danner RL; Elin RJ; Hosseini JM; Wesley RA; Reilly JM; Parillo JE
Chest; 1991 Jan; 99(1):169-75. PubMed ID: 1984950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
